Ciprofloxacin for treatment of malakoplakia

R van Furth1, J W van't Wout, P A Wertheimer

  • 1Department of Infectious Diseases, University Hospital Leiden, Netherlands.

Lancet (London, England)
|January 18, 1992
PubMed

Insights

Malakoplakia, a rare disease causing tumor-like lesions, can be effectively treated with the antibiotic ciprofloxacin. Long-term antibiotic therapy led to the complete disappearance of granulomatous lesions in patients with advanced malakoplakia.

Area of Science:

  • Infectious Diseases
  • Oncology
  • Pharmacology

Background:

  • Malakoplakia is a rare inflammatory condition characterized by tumor-like lesions.
  • These lesions, composed of macrophages with undigested coliform bacteria, are frequently misdiagnosed as carcinoma.
  • The exact etiology is likely infectious, but long-term antimicrobial therapies have historically been unsuccessful.

Observation:

  • Ciprofloxacin demonstrates good penetration into macrophages, the primary cells involved in malakoplakia.
  • Two patients with advanced malakoplakia were treated with ciprofloxacin at a dosage of 500 mg twice daily.
  • Long-term administration of ciprofloxacin resulted in the complete resolution of granulomatous lesions.

Findings:

  • Antibiotic treatment with ciprofloxacin can effectively resolve malakoplakia lesions.
  • The study suggests a successful therapeutic strategy for this rare disease.
  • Ciprofloxacin's efficacy highlights the potential of targeted antimicrobial therapy in malakoplakia.

Implications:

  • Malakoplakia may be curable with appropriate antibiotic treatment.
  • This finding could lead to improved diagnostic and treatment protocols for malakoplakia.
  • Further research into ciprofloxacin's role in managing malakoplakia is warranted.